Improving detection combined with targeted therapy for small hepatocellular carcinoma.
作者信息
Qiu Shengyang, Jiao Long R
机构信息
HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, London, UK.
出版信息
Ann Transl Med. 2019 Mar;7(Suppl 1):S4. doi: 10.21037/atm.2019.01.19.
Abstract
摘要
相似文献
1
Improving detection combined with targeted therapy for small hepatocellular carcinoma.改善小肝细胞癌的检测并联合靶向治疗。
Ann Transl Med. 2019 Mar;7(Suppl 1):S4. doi: 10.21037/atm.2019.01.19.
2
Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone.与单独使用常规 3T MRI 相比，在介入治疗后检测新的非常小的肝细胞癌病变时增加弥散加权成像。
Clin Radiol. 2012 Jul;67(7):669-74. doi: 10.1016/j.crad.2011.12.006. Epub 2012 Feb 14.
3
Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.使用携带羧肽酶G2的靶向腺病毒对肝细胞癌进行全身基因导向酶前药治疗。
Cancer Res. 2005 Jun 15;65(12):5003-8. doi: 10.1158/0008-5472.CAN-05-0393.
4
Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.经动脉化疗栓塞联合射频消融治疗直径大于3cm的肝细胞癌患者：一项随机对照试验
JAMA. 2008 Apr 9;299(14):1669-77. doi: 10.1001/jama.299.14.1669.
5
Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis.靶向与多功能技术在肝癌与肝硬化鉴别诊断中的应用
ACS Appl Mater Interfaces. 2019 Apr 24;11(16):14526-14537. doi: 10.1021/acsami.8b20600. Epub 2019 Feb 27.
6
[The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (<or=3 cm) detection].[屏气扩散加权成像在小肝细胞癌病灶（≤3cm）检测中的价值]
Zhonghua Yi Xue Za Zhi. 2009 Mar 10;89(9):592-6.
7
Latest developments in targeted therapy for hepatocellular carcinoma.肝细胞癌靶向治疗的最新进展。
Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146.
8
Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.利用免疫脂质体共递送阿霉素和核糖核苷酸还原酶 M2 siRNA 抑制肝癌生长。
Biomaterials. 2013 Dec;34(38):10084-98. doi: 10.1016/j.biomaterials.2013.08.088. Epub 2013 Sep 20.
9
Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.肝细胞癌非手术治疗的当前标准与未来展望
Digestion. 2017;96(1):1-4. doi: 10.1159/000464282. Epub 2017 Jun 13.
10
Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.肝细胞癌的临床特征、治疗及预后趋势
Hepatogastroenterology. 2003 Nov-Dec;50(54):1872-7.
引用本文的文献
1
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.癌症纳米技术：增强肿瘤细胞对化疗的反应以治疗肝细胞癌
Asian J Pharm Sci. 2019 Nov;14(6):581-594. doi: 10.1016/j.ajps.2019.04.005. Epub 2019 Jun 12.
本文引用的文献
1
Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.经皮超声/磁共振融合引导射频消融治疗复发性亚厘米级肝癌：技术可行性和治疗结果。
Radiology. 2018 Sep;288(3):878-886. doi: 10.1148/radiol.2018172743. Epub 2018 Jun 19.
2
Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging.有肝细胞癌病史患者中具有典型肝细胞癌影像学表现的亚厘米超血管结节：基于钆塞酸二钠增强MRI和扩散加权成像的自然病程
Eur Radiol. 2015 Sep;25(9):2789-96. doi: 10.1007/s00330-015-3680-9. Epub 2015 Mar 4.
3
Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention.实时超声与 CT 或 MRI 的融合成像在肝脏介入中的应用。
Ultrasonography. 2014 Oct;33(4):227-39. doi: 10.14366/usg.14021. Epub 2014 Jun 10.
4
Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound.融合影像引导下的射频消融治疗常规超声无法检测到的肝细胞癌。
AJR Am J Roentgenol. 2013 Nov;201(5):1141-7. doi: 10.2214/AJR.13.10532.
5
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.射频消融治疗肝细胞癌：10 年结果和预后因素。
Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578. doi: 10.1038/ajg.2011.425. Epub 2011 Dec 13.
6
Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection.CT 或 MRI 发现的小肝细胞癌的靶向超声检查：影响超声检测的因素。
AJR Am J Roentgenol. 2010 May;194(5):W396-400. doi: 10.2214/AJR.09.3171.
7
Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.肝细胞癌的射频消融：磁导航虚拟CT超声检查的价值
AJR Am J Roentgenol. 2008 Jun;190(6):W335-41. doi: 10.2214/AJR.07.3092.
8
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.经皮射频消融治疗肝细胞癌。1000例分析。
Cancer. 2005 Mar 15;103(6):1201-9. doi: 10.1002/cncr.20892.
9
Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.复发性肝细胞癌：肝切除术后经皮射频消融
Radiology. 2004 Jan;230(1):135-41. doi: 10.1148/radiol.2301021182. Epub 2003 Nov 20.
Zotero 插件